MedPath

Study of Effect of Myrtus extract on diabetic foot wounds

Phase 2
Conditions
Diabetic Foot Ulcers.
diabetes, With peripheral circulatory complications
Registration Number
IRCT2016020626394N1
Lead Sponsor
Vice chancellor for research, Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
70
Inclusion Criteria

Proved diabetes; clinical findings indicative for wound infection (redness, swelling and discharge; diabetic foot wound), wounds on toes; foot, the heel and top of the toe; body mass index 18 to 35; full consciousness, age 20 to 80 years.
The exclusion criteria: drugs and alcohol abuse; chronic disease other than diabetes affects the healing process of wounds such as severe vascular disease, lupus, rheumatoid arthritis, burgers and kidney failure; Immunosuppressive and cytotoxic drug users.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Grade of diabetic foot ulcers. Timepoint: Before the intervention and every weeks up to four weeks after the intervention. Method of measurement: Grade and depth of diabetic foot ulcers in both control and experimental groups before the intervention, according to the University of Texas wound classification system will be assessed by the investigator.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath